Precision Medicine

Various shades of blue sewing thread spools
Biotech

Amgen weaves in UK biotech with up to $840M acquisition

Amgen has stitched together a deal worth up to $840 million for Dark Blue Therapeutics, a private biotech in Oxford.
Gabrielle Masson Jan 6, 2026 10:35am
Two businessmen pushing giant puzzle pieces together as the sun sets behind them

2 European biotechs link to tackle neurodegenerative diseases

Oct 20, 2025 8:20am
immune system fighting cancer cells

Foundation Medicine awards new grant for biommarker testing push

Oct 6, 2025 8:45am
Tecentriq
Favicon Fierce Pharma

Roche touts Tecentriq biomarker win in bladder cancer

Aug 18, 2025 4:17pm
brain

Arialys presents promising data for IgG1 antibody treatment

Jun 20, 2025 5:02am
cellos without players

Bayer boosts precision oncology efforts with multiyear AI deal

Apr 23, 2025 12:55pm